OrbiMed’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-29,892
| Closed | -$38.4M | – | 121 |
|
|
2018
Q4 | $38.4M | Sell |
29,892
-5,558
| -16% | -$7.14M | 0.71% | 46 |
|
|
2018
Q3 | $67M | Sell |
35,450
-2,239
| -6% | -$4.23M | 0.81% | 38 |
|
|
2018
Q2 | $76.6M | Buy |
37,689
+11,009
| +41% | +$22.4M | 0.91% | 37 |
|
|
2018
Q1 | $59M | Sell |
26,680
-2,968
| -10% | -$6.56M | 0.73% | 47 |
|
|
2017
Q4 | $68.4M | Sell |
29,648
-7,558
| -20% | -$17.4M | 0.87% | 38 |
|
|
2017
Q3 | $66.2M | Buy |
37,206
+6,341
| +21% | +$11.3M | 0.63% | 47 |
|
|
2017
Q2 | $42M | Buy |
30,865
+8,956
| +41% | +$12.2M | 0.44% | 62 |
|
|
2017
Q1 | $25.8M | Hold |
21,909
| – | – | 0.29% | 71 |
|
|
2016
Q4 | $17.5M | Sell |
21,909
-69,635
| -76% | -$55.7M | 0.22% | 71 |
|
|
2016
Q3 | $80.4M | Hold |
91,544
| – | – | 0.92% | 43 |
|
|
2016
Q2 | $51.3M | Buy |
91,544
+18,551
| +25% | +$10.4M | 0.54% | 50 |
|
|
2016
Q1 | $40.2M | Buy |
72,993
+294
| +0.4% | +$162K | 0.42% | 54 |
|
|
2015
Q4 | $60.5M | Sell |
72,699
-19,084
| -21% | -$15.9M | 0.55% | 50 |
|
|
2015
Q3 | $102M | Buy |
91,783
+17,802
| +24% | +$19.7M | 1.03% | 34 |
|
|
2015
Q2 | $161M | Buy |
73,981
+31,467
| +74% | +$68.6M | 1.35% | 25 |
|
|
2015
Q1 | $66.5M | Buy |
+42,514
| New | +$66.5M | 0.57% | 49 |
|
|
2014
Q2 | – | Sell |
-22,311
| Closed | -$6.57M | – | 119 |
|
|
2014
Q1 | $6.57M | Buy |
+22,311
| New | +$6.57M | 0.08% | 96 |
|
|
2013
Q4 | – | Sell |
-17,177
| Closed | -$6M | – | 112 |
|
|
2013
Q3 | $6M | Buy |
+17,177
| New | +$6M | 0.11% | 84 |
|